Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05116254
Title Sarcomas and DDR-Inhibition; a Combined Modality Study (SADDRIN-1)
Acronym SADDRIN-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.